Automation Workflow for Polypharmacy and High-Risk Medication Review

This workflow automates a critical but often inconsistent safety review for patients on multiple medications (polypharmacy) or high-risk drugs like anticoagulants and opioids. It eliminates manual chart reviews by using agents to continuously analyze fused patient data—medication lists from the pharmacy system, lab values like renal function from the LIS, and diagnosis codes from the EHR—to calculate a dynamic risk score. The operational upside is direct: it reduces medication-related adverse events, prevents costly hospitalizations, and leverages clinical pharmacist time by pre-screening and prioritizing only the cases that require expert intervention.

Implementation integrates with core health systems like Epic, Cerner, or Oracle Health pharmacy modules via HL7/FHIR APIs. The orchestrator, built with a framework like LangGraph, manages the agentic retrieval, rule application, and task creation. A key architectural decision is designing the review interface within the clinician's existing workflow (e.g., EHR in-basket) to present fused data—drugs, labs, notes—coherently, minimizing click-through. Controls include configurable risk thresholds, mandatory human review for high-severity flags, and a full audit trail of the agent's logic and the reviewer's actions for compliance and quality assurance.

This workflow automates the critical but often manual safety review for patients on polypharmacy or high-risk drugs like anticoagulants and opioids. It eliminates the operational bottleneck of clinicians manually cross-referencing medication lists with lab values and diagnosis codes. The business value is direct: reduced adverse drug events, lower readmission risk, and significant pharmacist time savings by pre-screening and prioritizing only the cases that require expert intervention, based on fused clinical data from the EHR and pharmacy systems.

Implementation integrates with Epic or Cerner via FHIR APIs to ingest medication lists, renal function labs, and diagnosis codes. The orchestrator, built with LangGraph, manages specialized agents for drug-drug interaction checking, renal dosing adjustment, and fall risk assessment. A key control is the configurable review interface, which presents the fused patient narrative and risk rationale to the pharmacist, requiring an explicit sign-off. Observability is built in, logging all agent decisions and review actions for audit trails and continuous model validation against clinical outcomes.

Phase 1 establishes the core data fusion and risk-detection engine. We integrate with the EHR (Epic, Cerner) and pharmacy system via HL7/FHIR to ingest real-time medication lists, lab values (e.g., eGFR for renal dosing), and diagnosis codes. An orchestration layer, built with LangGraph, triggers a rules-based agent to apply institutional logic (e.g., Beers Criteria, anticholinergic burden scores) and an LLM agent for nuanced context analysis from clinical notes. Identified high-risk cases are queued in a secure database, creating the foundational automated triage layer with full auditability.

Phase 2 focuses on the human-in-the-loop interface and exception handling. We build a dedicated review module within the clinical workspace, presenting the fused patient data, risk score, and AI rationale to pharmacists or geriatricians. The orchestrator manages task assignment, escalation timers, and documentation write-back. Phase 3 begins with a controlled pilot on a geriatrics unit, measuring time-to-review and intervention rates. Post-pilot, we refine alert logic to reduce false positives and implement granular approval gates before scaling enterprise-wide, ensuring the workflow demonstrably reduces adverse drug events and clinician cognitive load.

This workflow automates a critical but often inconsistent safety review, targeting patients on polypharmacy regimens, anticoagulants, or opioids. It ingests medication lists from pharmacy systems like Epic Willow, lab values (e.g., renal function), and diagnosis codes to calculate a dynamic risk score. The operational upside is a 70-80% reduction in manual chart review time for pharmacists and geriatricians, directly lowering the risk of adverse drug events and associated readmissions. Implementation requires building agents for data fusion, a rules engine for risk logic, and secure integration with clinical APIs.

The architecture centralizes on an orchestrator like LangGraph, managing agents for data retrieval, risk assessment, and task creation. Controls are essential: all high-risk flags require human review in a purpose-built interface presenting fused data. A phased rollout starts with a single high-risk drug class (e.g., direct oral anticoagulants) and one clinical unit, validating risk logic and review workflows before scaling. Governance includes monitoring false-positive rates, review cycle times, and integrating findings back into the rules engine for continuous improvement.

A production-grade polypharmacy review workflow automates a critical safety check that is often ad-hoc, reducing pharmacist and geriatrician cognitive load while mitigating adverse drug event risk. The business value is clear: lower hospital readmissions, reduced liability, and more efficient use of specialist time. Implementation requires integration with pharmacy dispensing systems (e.g., Epic Willow, Cerner PharmNet) and the EHR to ingest medication lists, lab values (e.g., eGFR for renal dosing), and diagnosis codes in real-time.

The review interface must present fused patient data—medication history, renal/hepatic function, age, comorbidities—to enable rapid, informed decision-making. Controls are essential: configurable risk thresholds, mandatory pharmacist review for high-severity flags, and an immutable audit trail of all agent actions and clinical overrides. Rollout should be phased, starting with a pilot on high-risk units like geriatrics or oncology, with continuous monitoring of alert accuracy and clinician feedback to refine logic and reduce alert fatigue.